Federal contract award
75N92025P00148
[25-007778] DR. HONG, DR. WIESNTER AND DR. DUNBAR REQUIRES ESSENTIAL SUPPLIES IN ORDER TO PERFORM THESE TASKS: OPTIMIZING NK TRANSDUCTION EFFICIENCY AND STUDY CAR-NK CELLS FUNCTION IN VITRO AND IN VIVO; TO STUDY THE ANTI-TUMOR RESPONSE OF GENE MODIFI
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NHLBI |
| NAICS | 325414 — Biological Product (except Diagnostic) Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $20.9K |
| Current contract value | $20.9K |
| Potential contract value / ceiling | $20.9K |
| Start date | Apr 3, 2025 |
| Current end date | Jun 3, 2025 |
| Potential end date | Jun 3, 2025 |
| Latest award activity | Apr 9, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 9, 2025 | 0 | $20.9K | [25-007778] DR. HONG, DR. WIESNTER AND DR. DUNBAR REQUIRES ESSENTIAL SUPPLIES IN ORDER TO PERFORM THESE TASKS: OPTIMIZING NK TRANSDUCTION EFFICIENCY AND STUDY CAR-NK CELLS FUNCTION IN VITRO AND IN VIVO; TO STUDY THE ANTI-TUMOR RESPONSE OF GENE MODIFI |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.